Skip to menu Skip to content Skip to footer
Course profile

Drug Design and Formulation (PHIP7121)

Study period
Sem 1 2025
Location
External
Attendance mode
Online

Course overview

Study period
Semester 1, 2025 (24/02/2025 - 21/06/2025)
Study level
Postgraduate Coursework
Location
External
Attendance mode
Online
Units
4
Administrative campus
Dutton Park
Coordinating unit
Pharmacy and Pharmaceutical Sciences School

Students studying this course will gain a foundation in concepts integral to pharmaceutical industry led drug discovery and dosage form design. Students will acquire knowledge about advanced drug delivery methods; high throughput drug discovery techniques; and the importance of biotechnology approaches in current and future therapies to treat a variety of diseases. Students will demonstrate an understanding of key dosage form design theories, teamwork skills and good laboratory practice through learning activities where students will apply theoretical knowledge and research skills to gain an understanding of processes required to formulate a pharmaceutical product. Students will also engage in a pharmaceutical company like presentation to develop their research and communications skills and to enhance their understanding of the intersect between cutting edge research developments and advances in patient care. Students will hear from and meet pharmaceutical industry professionals to gain even deeper insights into the topics and core skills which are features of this course.

Welcome to the course profile for PHIP7121, a part of the Masters of Pharmaceutical Industry Practice (MPIP). Please email or see the course co-ordinator for any clarification around any assessment or policy information.

Course requirements

Restrictions

MPharmIndPrac students only

Course contact

Course coordinator

Associate Professor Peter Moyle

Consultation:

Students can ask questions relating to course content via several avenues.


For course related questions, that are not of a personal nature, use the following options:

Ed Discussion Board: Questions posted to the Ed Discussion Board, and responses, will be visible to other students. Students are welcome to attempt to answer, or to discuss questions in the discussion board. Before posting a question, please search the Ed Discussion Board to ensure that the question has not already been asked.

Timetabled Teaching Sessions: Students can ask questions relating to course content during timetabled lectures or workshops.


For questions of a personal nature, use the following options:

Email: Personal questions can be submitted via email (p.moyle@uq.edu.au).

Course staff

Timetable

The timetable for this course is available on the UQ Public Timetable.

Aims and outcomes

This course aims to develop your research skills, critical thinking abilities, skills to work effectively in teams and your oral and written communications skills. The course aims to give you insights into the complexity and importance of pharmaceutical formulation approaches as well as pharmaceutical industry approaches to drug discovery. It also seeks to provide you with a hands-on understanding of good laboratory practice and pharmaceutical development.

Learning outcomes

After successfully completing this course you should be able to:

LO1.

Present and discuss new approaches in drug discovery and therapeutic development

LO2.

Acquire and apply formulation knowledge to the research and development of a simple pharmaceutical product

LO3.

Integrate and apply a range of formulation concepts in the science of dose form design

LO4.

Independently source and analyse evidence that is important in the formulation and evaluation of pharmaceuticals

LO5.

Propose and justify a range of evaluation methods for a specific pharmaceutical product

LO6.

Apply good manufacturing and good laboratory practice including time management skills

LO7.

Work effectively in a pharmaceutical research team

LO8.

Demonstrate knowledge of advanced drug formulations

Assessment

Assessment summary

Category Assessment task Weight Due date
Presentation, Poster Poster Presentation
  • Identity Verified
  • In-person
  • Online
25%

28/03/2025 9:00 am

Students will present their poster at a session on this day. The beginning of this session will constitute the due date and time for this assessment.

Paper/ Report/ Annotation, Essay/ Critique, Project Formulation Prework and Plan (Group assessment)
  • Team or group-based
15%

17/04/2025 2:00 pm

Quiz Advanced Drug/Vaccine Delivery Quiz
  • Online
10%

23/05/2025 2:00 pm

This quiz will be available for completion from immediately after the Advanced Drug Delivery lecture until this deadline.

Notebook/ Logbook, Practical/ Demonstration Good Laboratory Practice (Individual assessment)
  • Online
10%

30/05/2025 2:00 pm

Paper/ Report/ Annotation Integrating Theory (Individual assessment)
40%

12/06/2025 2:00 pm

Assessment details

Poster Presentation

  • Identity Verified
  • In-person
  • Online
Mode
Oral
Category
Presentation, Poster
Weight
25%
Due date

28/03/2025 9:00 am

Students will present their poster at a session on this day. The beginning of this session will constitute the due date and time for this assessment.

Other conditions
Student specific, Time limited.

See the conditions definitions

Learning outcomes
L01

Task description

Poster Presentation (Individual Assessment): Pharmaceutical discovery and development poster

  • This assessment task is designed to enhance your ability to communicate advanced concepts related to pharmaceutical discovery and development in a format commonly used in scientific, clinical or education conferences and to exchange information between colleagues.
  • This assessment task is based on the following premise: You have been asked to present as a part of a series of short presentations (in digital poster format) at an educational workshop as part of the induction of new staff at a pharmaceutical company you work for. The new staff have just completed undergraduate degrees in Pharmaceutical Science and/or Pharmacy. The workshop is designed to inform new staff about some of the new methods your company is using or is considering using in their drug discovery and development programs. You are asked to present a digital poster presentation of no more than 4 minutes (you will be stopped at 4 minutes), the presentation should provide a basic overview of the method/approach that is assigned to you.
  • The method/approach will be assigned in week 1.
  • Your presentation should focus on how the approach/method can be used in pharmaceutical discovery and development. You will be asked a series of questions for 5 minutes after your presentation. Questions will be mostly general since the presentation is to an audience who are not experts in the topic. The audience may also ask you to explain specific aspects in more detail.
  • Students should attend the session in which they are presenting (~ 8-10 talks per session).
  • The Oral Presentation will be recorded and retained as per university policy. The recording will be stored in a secure manner and will only be accessed if required for the purposes of moderation of marking; provision of feedback to the student; and/or re-marking following a successful re-mark application.

Every student must submit a PDF document containing their poster, a page of consistent references (Vancouver style) and a copy of their student ID card to the assessor via the Learn.UQ Poster Presentation assessment link prior to the commencement of their poster presentation session.

Internal enrolled students will give their presentation to their assessor and other students in person (room details provided on the course Learn.UQ site). Please arrive early to upload your presentations (from USB type A flash drive) to the lectern computer. In the event that in person presentations cannot occur, the presentations will be given over Zoom.

External enrolled students will give their presentations via Zoom. Zoom link details will be advised on Learn.UQ.

Poster Style:

Your digital poster should be presented as a SINGLE 16:9 (widescreen) aspect ratio PowerPoint slide for projection or screen sharing. Students should bring their PowerPoint compatible slide on a USB flash drive if presenting in the lecture theatre, or be prepared to present via Zoom (using share screen) if presenting online. The SINGLE slide must contain no movies, transitions or animations (i.e. the slide must be static).

Requirements for the posters are as follows:

  • The poster must contain a clear title.
  • The bottom left-hand corner of your poster must contain your name.
  • The use of tables, diagrams and/or images to explain concepts is strongly encouraged. 
  • The use of bullet point text is also strongly encouraged.
  • Font size, style, colour, background colour and images should allow for clear reading of the poster when presented. The font sizes used in the example poster on the PHIP7121 UQ Extend site are appropriate and should be used as a guide. 

The marking criteria is available on the assessment page on the course Learn.UQ (Blackboard) site.

Tips:

  • An example poster with an example presentation is available on the UQ Extend site. 
  • Consult the marking criteria and the example poster provided before designing your poster and preparing your speech.
  • Rehearse with your friends and seek feedback for improvement.
  • Record yourself practicing your presentation using Zoom, and watch the recording back to experience what your assessor and colleagues will experience.
  • If presenting via Zoom, ensure that you are in a location with a reliable internet connection on the presentation day, and that you are familiar with using Zoom, including setting up your microphone, webcam, and sharing your computer screen.

Marking: The marking rubric is available on the PHIP7121 Learn.UQ site under assessments.

Generative AI and Machine Translation (MT): This task has been designed to be challenging, authentic and complex. Whilst students may use Artificial Intelligence (AI) and Machine Translation (MT) technologies, successful completion of the assessment will require students to critically engage in specific contexts and tasks for which AI will provide only limited support and guidance. A failure to reference AI or MT use may constitute student misconduct under the Student Code of Conduct. To pass this assessment, students will be required to demonstrate detailed comprehension of their written submission independent of AI and MT tools.

Submission guidelines

Submission: A PDF document (poster, references, student ID) should be submitted electronically to the Learn.UQ (Blackboard) site for this course prior to your in person presentation.

Deferral or extension

You may be able to defer this exam.

Late submission

A penalty of 10% of the maximum possible mark will be deducted per 24 hours from time submission is due for up to 7 days. After 7 days, you will receive a mark of 0.

Formulation Prework and Plan (Group assessment)

  • Team or group-based
Mode
Written
Category
Paper/ Report/ Annotation, Essay/ Critique, Project
Weight
15%
Due date

17/04/2025 2:00 pm

Other conditions
Student specific, Time limited.

See the conditions definitions

Learning outcomes
L02, L03, L04, L07

Task description

Formulation Prework and Plan (Group assessment): Prework for “formulate a pharmaceutical” task.

  • This assignment should be collaboratively completed by the group. One submission will be made per group.
  • Prepare a single Microsoft Word (.docx) document using the questions below as the headings.
  • Use a range of academic resources including journal articles, books, pharmacopoeias etc. to support your responses and remember to consistently cite your statements using Vancouver style (with superscript citations) as per the UQ Library’s Referencing Guide (link). This assessment task will be analysed by TurnItIn software for similarity to other documents and assessment submissions. Group members should ensure that the assessment does not copy material directly from other sources and is appropriately referenced.
  • Groups and pharmaceutical products to be formulated will be allocated early in semester, and the list will be provided on Learn.UQ.
  • All students will be allocated a suspension formulation to produce in the laboratory sessions, which will be used for answering questions 1-5 below. For question 6, each group will answer the questions relating to suspensions as well as the questions associated the additional formulation type that they have been allocated in the syndicate list document.

The outline of your pre-work should be as follows (Q1-6):

  1. What is your assigned product and concentration/amount of the active ingredient? (1 line)
  2. What is the primary therapeutic indication for your product and how is the product taken/administered? (1-2 sentences, < 60 words)
  3. What existing similar products are commercially available? If your drug is not currently used state this and why it may no longer be used (1-2 sentences, < 60 words).
  4. What are the possible chemical degradation (not metabolism) pathways of your drug (active ingredient)? What factors affect its stability? (< 200 words)
  5. Identify characteristics you want to avoid in your final product (e.g. not pourable, hard to spread, breaks easily). (< 200 words)

***For question 6 please answer the specific questions below relating to SUSPENSIONS as well as the questions associated with your groups additional allocated dosage form***

ALL groups should complete the following questions on SUSPENSIONS (Q6):

6a. When formulating a pharmaceutical suspension, you should first assess what happens when your drug is added to water. What might be required if the drug floats on the top of the water and is not wetted? (<30 words).

6b. Explain what Stoke's Law is and how it relates to pharmaceutical suspensions (<30 words).

6c. How can sedimentation rates be reduced? i.e. describe methods to achieve this (<30 words)

6d. When formulating a suspension, do you want your drug to be soluble? What factors affect solubility? (<30 words)

Additional questions for groups who have been assigned TABLETS (Q6):

6e. Step one in formulating tablets is to find out if your drug particles are free flowing. What measures might be necessary if the drug doesn't flow well or adheres to the punches or die? (<30 words)

6f. List the types of excipients used in tableting. Describe the function of each excipient type (< 10 words for each type).

6g. In one sentence (<30 words), define granulation.

6h. Name two granulation methods. (< 30 words)

Additional questions for groups who have been assigned CREAMS (Q6):

6e. Step one in formulating a pharmaceutical cream is to formulate a base cream without your active ingredient. Define the types of external and internal phases that creams can have? (<30 words)

6f. What is meant by 'cracking' with respect to creams? (<30 words)

6g. What is an emulsifying agent? (<30 words)

6h. Does your active ingredient have a charge? How could this affect your choice of emulsifying agent? (<30 words)

Additional questions for groups who have been assigned GELS (Q6):

6e. Step one in formulating a pharmaceutical gel is to formulate a base gel without your active ingredient. What types of agents are used to produce a pharmaceutical gel? (<30 words)

6f. What are the advantages and disadvantages of a gel product compared to a cream based product? (<30 words)

6g. What is syneresis? (<30 words)

6h. Do you want your active ingredient to be dissolved or suspended as particles in a gel? Why? (<30 words)

The marking rubric is available on the PHIP7121 Learn.UQ site under assessments.

Generative AI and Machine Translation (MT): This task has been designed to be challenging, authentic and complex. Whilst students may use Artificial Intelligence (AI) and Machine Translation (MT) technologies, successful completion of the assessment will require students to critically engage in specific contexts and tasks for which AI will provide only limited support and guidance. A failure to reference AI or MT use may constitute student misconduct under the Student Code of Conduct. To pass this assessment, students will be required to demonstrate detailed comprehension of their written submission independent of AI and MT tools.

Submission guidelines

Submission: Once the team has agreed to submit the final document, one group member should submit the Microsoft Word (.docx) document to the assessment link on Learn.UQ.

Deferral or extension

You may be able to apply for an extension.

The maximum extension allowed is 28 days. Extensions are given in multiples of 24 hours.

Extension requests for a group assessment item require at least 50% of your group members to also agree to the request for an extension and completion of the form at this link: Applying for an assessment extension - my.UQ - University of Queensland

Late submission

A penalty of 10% of the maximum possible mark will be deducted per 24 hours from time submission is due for up to 7 days. After 7 days, you will receive a mark of 0.

Advanced Drug/Vaccine Delivery Quiz

  • Online
Mode
Written
Category
Quiz
Weight
10%
Due date

23/05/2025 2:00 pm

This quiz will be available for completion from immediately after the Advanced Drug Delivery lecture until this deadline.

Other conditions
Time limited.

See the conditions definitions

Learning outcomes
L08

Task description

Online quiz relating to the content taught in the advanced drug delivery and vaccine development lectures.

The quiz consists of 10 randomised multiple choice questions, with 1 mark per question.

Submission guidelines

The quiz will be completed in Learn.UQ via the link on the assessment page. Students have a single attempt at completing the quiz.

Deferral or extension

You may be able to apply for an extension.

The maximum extension allowed is 28 days. Extensions are given in multiples of 24 hours.

Late submission

A penalty of 10% of the maximum possible mark will be deducted per 24 hours from time submission is due for up to 7 days. After 7 days, you will receive a mark of 0.

Good Laboratory Practice (Individual assessment)

  • Online
Mode
Product/ Artefact/ Multimedia
Category
Notebook/ Logbook, Practical/ Demonstration
Weight
10%
Due date

30/05/2025 2:00 pm

Other conditions
Student specific.

See the conditions definitions

Learning outcomes
L06

Task description

The objective of the Good Laboratory Practice (GLP) task is to ensure that students are able to successfully implement GLP.

Internal Students will participate in drug formulation laboratory sessions, which will provide the content for completing this assessment task and the integrating theory task. Select and submit 3 consecutive pages from your drug formulation laboratory notebook to submit for this assessment task. The final formulated product for your group (with all group members names attached) should be submitted at the end of the final drug formulation laboratory class to complete this assessment task. Students will need a lab book for their drug formulation laboratories, from which the GLP assessment will be sourced. This can be a commercially sourced lab book, or a bound (not spiral bound) ruled notebook.

External students will create 3 example laboratory book pages based on the laboratory activities that they observe in the virtual formulation lab sessions (videos for weeks 1-4) on the PHIP7121 UQ Extend site (Module 7 - Virtual Practical). In all cases for this virtual task, the student should act as the "other person" and self-role play another name. Select any parts of the virtual pracs for this assessment, use your imagination. If you do not have the information, you have the right to create 'appropriate' data to enable completion of this task. Additional data and images and a final formulation recipe have been provided on UQ Extend to assist. Screenshots from the virtual practical videos may be incorporated into lab books where visual data is required. A 3 page laboratory notebook template is provided for external students to use at the PHIP7121 Learn.UQ assessment link.

Marking: Laboratory notebook entries will be assessed for their compliance with good laboratory practice and record-keeping. Students should refer to the PHIP7121 UQ Extend site (Module 4, part 2) for more details and a GLP rules guide, and consult the marking rubric that is available on the PHIP7121 Learn.UQ site on the Assessments page.

Submission guidelines

Submission: Scan 3 consecutive laboratory book pages to PDF and submit electronically via the Learn.UQ (Blackboard) assessment task link for this course.

Deferral or extension

You may be able to apply for an extension.

The maximum extension allowed is 28 days. Extensions are given in multiples of 24 hours.

Late submission

A penalty of 10% of the maximum possible mark will be deducted per 24 hours from time submission is due for up to 7 days. After 7 days, you will receive a mark of 0.

Integrating Theory (Individual assessment)

Mode
Written
Category
Paper/ Report/ Annotation
Weight
40%
Due date

12/06/2025 2:00 pm

Other conditions
Student specific.

See the conditions definitions

Learning outcomes
L02, L03, L04, L05

Task description

One of the learning objectives of this course is for you to apply concepts in the science of dosage form design. This assessment task will assess this ability. You are strongly encouraged to examine the marking criteria for this task before starting.

Select ONE of the following dosage form design concepts or dosage form design features that is relevant to your final product and answer the questions below.

  1. Foaming 
  2. Plastic flow
  3. Dilatant flow
  4. Pseudo-plastic flow
  5. Rheopexy
  6. Thixotropy
  7. Sedimentation
  8. Content uniformity
  9. Viscosity
  10. Caking 
  11. Syneresis 
  12. Co-solvents 
  13. Wetting 
  14. Cracking 
  15. Flowability 
  16. Compressibility 
  17. Hardness 
  18. Disintegration
  19. Creaming
  20. Surface and Interfacial tension

The final product for this assessment is the product that your group was allocated for the drug formulation laboratory sessions (internal students) or the formulation presented in the virtual formulation laboratory sessions (external students).

You may focus on a specific aspect of the above concepts for parts 5 and 6.

Part 1 - Reflection - This section must be between 500-750 words. Use material from UQ Extend, your observations in the formulation development activity and other sources to reflect on "why is research important in the pharmaceutical industry and why can it sometimes be challenging?"

Part 2 – What type of formulation is the topic of this essay?

Part 3 – Which dosage form design concept or feature did you select?

Part 4 – Provide a definition or description (in your own words) of the dosage form design concept or feature you have selected (150 words or less, no more than two figures).

Part 5 – Explain the significance of this dosage form design concept or feature, in theory, with respect to the practical application of the formulated product (300 words or less, no more than two figures and/or/photos). For example, for tablets and the concept of 'friability' - Tablets that have high friability are more likely to break into smaller pieces during transport. This could lead to the patient being unable to use the product (the tablet is broken into many parts making it impossible to use), a smaller dose administered than the stated dose of the tablet (if a section of the tablet has broken off and the patient still uses the product) or altered tablet disintegration ……..

Part 6 – Using observations made during the formulation development (lab sessions) describe how this dosage form design concept influenced your approach and consequently the final product (600 words or less, no more than four figures and/or photos and/or screen shots). For example, for tablets and the concept of 'friability' - Many of the first formulations exhibited high friability as demonstrated by ……… Hence we attempted to reduce friability through the addition of ………………. This agent acts via ……… The reduced friability of our final product was indicated by ………..

Marking: The marking rubric is available on the PHIP7121 Learn.UQ site under assessments. This assessment task will be analysed by TurnItIn software for similarity to other documents and assessment submissions and for signs that generative AI or contract cheating services were utilised. Students should ensure that the assessment does not directly copy or paraphrase written material from other sources and that content is appropriately referenced.

Generative AI and Machine Translation (MT): This task has been designed to be challenging, authentic and complex. Whilst students may use Artificial Intelligence (AI) and Machine Translation (MT) technologies, successful completion of the assessment will require students to critically engage in specific contexts and tasks for which AI will provide only limited support and guidance. A failure to reference AI or MT use may constitute student misconduct under the Student Code of Conduct. To pass this assessment, students will be required to demonstrate detailed comprehension of their written submission independent of AI and MT tools.

Submission guidelines

Submission: Submit electronically in Microsoft Word (.docx) format via the TurnItIn link on the Learn.UQ (Blackboard) site for this course.

Deferral or extension

You may be able to apply for an extension.

The maximum extension allowed is 28 days. Extensions are given in multiples of 24 hours.

Late submission

A penalty of 10% of the maximum possible mark will be deducted per 24 hours from time submission is due for up to 7 days. After 7 days, you will receive a mark of 0.

Course grading

Full criteria for each grade is available in the Assessment Procedure.

Grade Cut off Percent Description
1 (Low Fail) 1 - 29

Absence of evidence of achievement of course learning outcomes.

2 (Fail) 30 - 44

Minimal evidence of achievement of course learning outcomes.

3 (Marginal Fail) 45 - 49

Demonstrated evidence of developing achievement of course learning outcomes

4 (Pass) 50 - 64

Demonstrated evidence of functional achievement of course learning outcomes.

5 (Credit) 65 - 74

Demonstrated evidence of proficient achievement of course learning outcomes.

6 (Distinction) 75 - 84

Demonstrated evidence of advanced achievement of course learning outcomes.

7 (High Distinction) 85 - 100

Demonstrated evidence of exceptional achievement of course learning outcomes.

Supplementary assessment

Supplementary assessment is available for this course.

Additional assessment information

Use of Generative Artificial Intelligence (AI):ᅠStatements about the use of generative AI for completing assessment tasks have been incorporated into each assessment item description below. Generally the use of generative AI to generate responses to assessment questions is not permitted in this course. Generative AI may be used as a research tool, but its use should be cited, and the outputs not directly inserted into or paraphrased in assessment tasks. Students should be aware that the outputs of generative AI can be incorrect, biased, opaque or even nonsense, and thus students need to demonstrate comprehension of their submitted subject manner independent of the use of AI tools. Students are recommended to keep copies of versions of their assessment over time to provide support for their development and authorship of submitted assessment tasks.

Learning resources

You'll need the following resources to successfully complete the course. We've indicated below if you need a personal copy of the reading materials or your own item.

Library resources

Find the required and recommended resources for this course on the UQ Library website.

Other course materials

If we've listed something under further requirement, you'll need to provide your own.

Required

Item Description Further Requirement
Laboratory coat For your health and safety, you will not be allowed to enter the laboratory without this item own item needed
Safety glasses For your health and safety, you will not be allowed to enter the laboratory without this item own item needed

Additional learning resources information

Zoom: Access to Zoom via your UQ student account will be required for certain synchronous online classes each week.

Learning activities

The learning activities for this course are outlined below. Learn more about the learning outcomes that apply to this course.

Filter activity type by

Please select
Clear filters
Learning period Activity type Topic
Multiple weeks

From Week 1 To Week 3

Lecture

Lectures - Biotechnology and High-throughput Screening

Lecture series including an introduction to course content and assessment, biotechnology, drug discovery, high-throughput screening and rational drug design.

Learning outcomes: L01

Multiple weeks

From Week 1 To Week 13

Not Timetabled

UQ Extend Content

UQ Extend learning - working in industry, formulating a pharmaceutical product, dosage form design theory, effective communication, research in the pharmaceutical industry

Learning outcomes: L01, L02, L03, L04, L05, L06, L07, L08

Tutorial

Tutorials, self-directed learning and assistance

Tutorials and self-directed learning.

Learning outcomes: L01, L02, L03, L04, L05, L06, L07, L08

Multiple weeks

From Week 4 To Week 7

Lecture

Lectures - Pharmaceutical Formulation and Research Methods

Lecture series on pharmaceutical formulation, GLP, research methods and approaches to prepare students for the drug formulation labs.

Learning outcomes: L02, L04, L05

Multiple weeks

From Week 8 To Week 11
(14 Apr - 18 May)

Practical

Formulation activities (virtual lab activity)

(External Students) Apply research methods and understand how to formulate a pharmaceutical product.

Learning outcomes: L02, L03, L04, L05, L06, L07

Multiple weeks

From Week 8 To Week 12

Practical

Formulation activities (drug formulation lab)

(Internal Students) Apply research methods and understand how to formulate a pharmaceutical product

Learning outcomes: L02, L03, L04, L05, L06, L07

Multiple weeks

From Week 9 To Week 10

Lecture

Lectures - Advanced Drug and Vaccine delivery

Lectures on advanced drug and vaccine delivery.

Learning outcomes: L08

Multiple weeks

From Week 11 To Week 13

Lecture

Lectures - Careers in Drug Discovery in Industry

Guest lecturers with experience in pharmaceutical industry drug discovery discuss how to enter the pharmaceutical industry.

Learning outcomes: L01, L07

Policies and procedures

University policies and procedures apply to all aspects of student life. As a UQ student, you must comply with University-wide and program-specific requirements, including the:

Learn more about UQ policies on my.UQ and the Policy and Procedure Library.

You'll also need to be aware of the following policies and procedures while completing this course: